Haematology & Transfusion Science

Science

Laboratory errors in transfusion 2020

Anne Lockhart, IBMS representative on the Serious Hazards of Transfusion (SHOT) steering group, explains the latest annual report.

Resources

September Journal-Based Learning

Haematology & Transfusion Science

News

Experimental cancer blood test

A new method of analysing cancer patients’ blood for evidence of the disease could be up to 10 times more sensitive than previous methods, according to new research.

Haematology & Transfusion Science

Resources

July/August Journal-based learning

Haematology & Transfusion Science

Science

Emergency morphology

Professor Barbara J Bain covers some of the circumstances when blood films are vital.

Haematology & Transfusion Science

Science

External quality assesment in a pandemic

What impact has the lockdown had on UK NEQAS and the services it provides? Barbara De la Salle, Director of UK NEQAS Haematology, and colleagues explain.

Haematology & Transfusion Science

Science

Drive-through phlebotomy

Laboratory Manager Richard Wardle outlines the introduction of a drive-through phlebotomy service during the COVID-19 pandemic.

Haematology & Transfusion Science

News

Glucose-sensing neurons regulate blood sugar

Low blood sugar levels, known as hypoglycaemia, can be a life-threatening situation, especially for people with type 1 diabetes who rely on intensive insulin therapy to prevent blood sugar from going too high.

Haematology & Transfusion Science

Science

Setting up a Nightingale hospital transfusion service

Alison Muir, a Lead Scientist in Blood Transfusion, discusses the issues and challenges in setting up a transfusion service to help cope with the pandemic.

Haematology & Transfusion Science

Resources

May: Journal-based learning

Haematology & Transfusion Science

News

Convalescent plasma therapy

A US team of Johns Hopkins experts has created a clinical guidebook to help hospitals and medical centres rapidly scale up their ability to deliver so-called convalescent plasma therapy, which leverages immune system components found in the plasma portion of blood from people who have recovered from COVID-19.

Haematology & Transfusion Science